CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 145 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,573,000 | +36.2% | 10,300,000 | 0.0% | 2.40% | +56.5% |
| Q2 2023 | $112,785,000 | +25.6% | 10,300,000 | 0.0% | 1.53% | +14.9% |
| Q1 2023 | $89,816,000 | +39.1% | 10,300,000 | 0.0% | 1.33% | +38.0% |
| Q4 2022 | $64,581,000 | +79.1% | 10,300,000 | 0.0% | 0.96% | +44.9% |
| Q3 2022 | $36,050,000 | +18.6% | 10,300,000 | 0.0% | 0.67% | +11.0% |
| Q2 2022 | $30,385,000 | -5.1% | 10,300,000 | 0.0% | 0.60% | +2.6% |
| Q1 2022 | $32,033,000 | -8.0% | 10,300,000 | 0.0% | 0.58% | -1.3% |
| Q4 2021 | $34,814,000 | -7.4% | 10,300,000 | 0.0% | 0.59% | +0.3% |
| Q3 2021 | $37,595,000 | -16.3% | 10,300,000 | 0.0% | 0.59% | -24.3% |
| Q2 2021 | $44,908,000 | -4.0% | 10,300,000 | 0.0% | 0.78% | -3.3% |
| Q1 2021 | $46,762,000 | -20.9% | 10,300,000 | 0.0% | 0.81% | -20.6% |
| Q4 2020 | $59,122,000 | -20.7% | 10,300,000 | 0.0% | 1.02% | -3.9% |
| Q3 2020 | $74,572,000 | +307.0% | 10,300,000 | +96.2% | 1.06% | +192.5% |
| Q2 2020 | $18,323,000 | +125.1% | 5,250,000 | -4.5% | 0.36% | +31.6% |
| Q1 2020 | $8,140,000 | -24.5% | 5,500,000 | 0.0% | 0.28% | -13.2% |
| Q4 2019 | $10,780,000 | -22.0% | 5,500,000 | +103.7% | 0.32% | -45.1% |
| Q3 2019 | $13,824,000 | -28.5% | 2,700,000 | 0.0% | 0.58% | -13.6% |
| Q2 2019 | $19,332,000 | +100.8% | 2,700,000 | +272.4% | 0.67% | +60.6% |
| Q1 2019 | $9,628,000 | -44.1% | 725,000 | -43.5% | 0.42% | -37.2% |
| Q2 2018 | $17,209,000 | – | 1,282,374 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |